Who is sponsoring NCT06333691?

NCT06333691 is sponsored by Minia University.

What condition does NCT06333691 study?

NCT06333691 studies Ovarian Hyperstimulation Syndrome.

What drugs are being tested in NCT06333691?

Interventions: Calcium Gluconate.

What is the status of NCT06333691?

NCT06333691 is currently COMPLETED.

Last reviewed 2025-01-07 · How we verify

Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin

NCT06333691 NA COMPLETED

Ovarian hyperstimulation syndrome is a potentially fatal iatrogenic condition. This syndrome is characterized by a sudden increase of the vascular permeability which results in the development of a massive extravascular exudate in the peritoneal cavity, pleural, pericardium causing ascites, pleural and pericardial effusion. Severe forms are also accompanied by electrolyte disturbances and cardiopulmonary, hepatic, renal, and hemoconcentration associated with increased thromboembolic risk. This syndrome is avoidable by the judicious use of gonadotropins and careful monitoring of stimulation regimens.

Details

Lead sponsor	Minia University
Phase	NA
Status	COMPLETED
Enrolment	180
Start date	Sat Oct 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Feb 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Ovarian Hyperstimulation Syndrome

Interventions

Calcium Gluconate

Countries

Egypt